Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Animal Health | 607.1 | 545.7 | 526.9 | 532.0 | 531.7 | 497.7 | 486.1 | 53.4 |
Mineral Nutrition | 259.5 | 220.6 | 214.4 | 233.8 | 234.9 | 218.3 | 216.7 | 227.1 |
Performance Products | 75.7 | 67.1 | 59.0 | 62.2 | 53.3 | 48.2 | 48.7 | 50.7 |
Other | | | | | | | | 417.4 |
Total revenues | 942.3 | 833.4 | 800.4 | 828.0 | 820.0 | 764.3 | 751.5 | 748.6 |
Revenue growth [+] | 13.1% | 4.1% | -3.3% | 1.0% | 7.3% | 1.7% | 0.4% | 8.2% |
Animal Health | 11.2% | 3.6% | -1.0% | 0.0% | 6.8% | 2.4% | 811.0% | 28.8% |
Mineral Nutrition | 17.7% | 2.9% | -8.3% | -0.5% | 7.6% | 0.7% | -4.6% | 12.7% |
Performance Products | 12.9% | 13.6% | -5.1% | 16.7% | 10.6% | -1.0% | -3.9% | -14.5% |
Cost of goods sold | 656.9 | 562.0 | 543.5 | 563.4 | 553.1 | 516.0 | 512.5 | 515.3 |
Gross profit | 285.4 | 271.4 | 256.9 | 264.6 | 266.9 | 248.2 | 239.0 | 233.3 |
Gross margin | 30.3% | 32.6% | 32.1% | 32.0% | 32.5% | 32.5% | 31.8% | 31.2% |
Selling, general and administrative | 206.4 | 196.5 | 187.7 | 181.4 | 168.0 | 150.3 | 153.3 | 145.6 |
EBITDA [+] | 111.7 | 106.8 | 101.5 | 110.8 | 125.9 | 123.9 | 109.2 | 109.3 |
EBITDA growth | 4.6% | 5.1% | -8.4% | -12.0% | 1.6% | 13.5% | -0.1% | 28.2% |
EBITDA margin | 11.9% | 12.8% | 12.7% | 13.4% | 15.4% | 16.2% | 14.5% | 14.6% |
Depreciation | 23.8 | 23.2 | 23.5 | 21.5 | 21.1 | 20.1 | 17.9 | 17.0 |
EBITA | 87.9 | 83.6 | 78.1 | 89.3 | 104.8 | 103.9 | 91.3 | 92.2 |
EBITA margin | 9.3% | 10.0% | 9.8% | 10.8% | 12.8% | 13.6% | 12.1% | 12.3% |
Amortization of intangibles | 8.9 | 8.7 | 8.9 | 6.1 | 5.9 | 6.0 | 5.6 | 4.6 |
EBIT [+] | 79.0 | 74.9 | 69.2 | 83.2 | 98.9 | 97.9 | 85.7 | 87.7 |
EBIT growth | 5.5% | 8.2% | -16.9% | -15.9% | 1.0% | 14.2% | -2.2% | 37.4% |
EBIT margin | 8.4% | 9.0% | 8.6% | 10.1% | 12.1% | 12.8% | 11.4% | 11.7% |
Interest expense, net [+] | 11.9 | 12.9 | 12.9 | 11.8 | 11.9 | 14.9 | 16.6 | 14.1 |
Interest expense | 11.9 | 12.9 | 12.9 | 11.8 | 11.9 | 14.9 | 16.6 | 14.3 |
Interest income | | | | | | | | 0.2 |
Other income (expense), net [+] | 5.2 | 4.5 | -0.8 | 0.1 | 1.1 | -2.5 | 7.6 | 5.2 |
Gain (loss) on debt retirement | | | | | | -2.6 | | |
Gain (loss) on foreign currency transactions | -5.2 | -4.5 | 0.8 | -0.1 | -1.1 | -0.1 | -7.6 | -5.4 |
Pre-tax income | 72.3 | 66.5 | 55.5 | 71.5 | 88.1 | 80.5 | 76.8 | 78.8 |
Income taxes | 23.2 | 12.1 | 22.0 | 16.8 | 23.2 | 15.9 | -6.0 | 18.5 |
Tax rate | 32.0% | 18.2% | 39.6% | 23.5% | 26.3% | 19.8% | | 23.5% |
Net income | 49.2 | 54.4 | 33.6 | 54.7 | 64.9 | 64.6 | 82.7 | 60.3 |
Net margin | 5.2% | 6.5% | 4.2% | 6.6% | 7.9% | 8.5% | 11.0% | 8.1% |
|
Basic EPS [+] | $1.21 | $1.34 | $0.83 | $1.35 | $1.61 | $1.63 | $2.11 | $1.55 |
Growth | -9.6% | 62.0% | -38.7% | -16.2% | -1.2% | -22.4% | 36.2% | -1692.5% |
Diluted EPS [+] | $1.21 | $1.34 | $0.83 | $1.35 | $1.61 | $1.61 | $2.07 | $1.51 |
Growth | -9.6% | 62.1% | -38.6% | -16.0% | -0.4% | -22.1% | 36.7% | -1658.7% |
|
Dividends per share [+] | $0.48 | $0.48 | $0.48 | $0.46 | $0.40 | $0.40 | $0.40 | $0.40 |
Growth | 0.0% | 0.0% | 4.3% | 15.0% | -0.1% | 0.1% | 0.0% | -51.2% |
|
Shares outstanding (basic) [+] | 40.5 | 40.5 | 40.5 | 40.4 | 40.2 | 39.5 | 39.3 | 39.0 |
Growth | 0.1% | 0.0% | 0.1% | 0.6% | 1.7% | 0.7% | 0.7% | 21.0% |
Shares outstanding (diluted) [+] | 40.5 | 40.5 | 40.5 | 40.5 | 40.4 | 40.0 | 40.0 | 39.8 |
Growth | 0.0% | 0.0% | 0.0% | 0.3% | 0.9% | 0.2% | 0.4% | 23.7% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|